Human Parvovirus B19 Infection in Multiple Sclerosis | Citedby Results | European Neurology | Karger Publishers

Skip to Main Content

Skip Nav Destination

Human Parvovirus B19 Infection in Multiple Sclerosis

Eur Neurol (1999) 42 (1): 36–40.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Parvovirus B19 and mumps virus antibodies are major constituents of the intrathecal immune response in European patients with MS and increase the diagnostic sensitivity and discriminatory power of the MRZ reaction

S. Jarius
D. Wilken
J. Haas
K. Ruprecht
L. Komorowski
B. Wildemann

Journal of Neurology (2021) 268 (10): 3758.

Viremia preceding multiple sclerosis: Two nested case-control studies

Emilie Hultin
Laila Sara Arroyo Mühr
Zurab Bzhalava
Maria Hortlund
Camilla Lagheden
Peter Sundström
Joakim Dillner

Virology (2018) 520: 21.

Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review

Kyla A. McKay
Shayesteh Jahanfar
Tom Duggan
Stacey Tkachuk
Helen Tremlett

NeuroToxicology (2017) 61: 189.

Tumor necrosis factor (TNF)α and its soluble receptor (sTNFR) p75 during acute human parvovirus B19 infection in children

Judith Barash
Doron Dushnitzki
Yigal Barak
Shmuel Miron
Talia Hahn

Immunology Letters (2003) 88 (2): 109.

Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin‐6 synthesis: Common pathway in inflammatory sequelae of human parvovirus infections?

Leslie Ann Mitchell

Journal of Medical Virology (2002) 67 (2): 267.